FDA Approved: LENALIDOMIDE — Supplemental Application (Teva Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for lenalidomide by Teva Pharmaceuticals, approving changes related to the drug's use.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Follicular Lymphoma
• Mantle Cell Lymphoma
• Multiple Myeloma
• Myelodysplastic Syndromes
• Myelodysplastic Syndromes with 5q Deletion
• Small Lymphocytic Lymphoma

Drugs mentioned

• Lenalidomide (lenalidomide)

Snippet

SUPPL AP for LENALIDOMIDE (LENALIDOMIDE)